Product/Composition:- | Citicoline |
---|---|
Strength:- | 250 mg, 500 mg, 1000 mg |
Form:- | Oral Tablets/Capsules |
Reference Brands:- | Cognizin®(US); Somazina®, NeurAxon®, Ceraxon®(EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Citicoline is a cognitive enhancer and neuroprotective agent used in stroke recovery and brain injury management. Available in oral (250–1000 mg) and injectable forms, it is marketed as Somazina (EU) and Cognizin (US). Pharmaceutical buyers source Citicoline for neurology-focused B2B demand and institutional supply chains.
Citicoline, a neuroprotective agent, is widely used to enhance cognitive function and support recovery from stroke, traumatic brain injury, and neurodegenerative diseases. Available in oral and injectable forms, Citicoline is marketed in the EU under brands like Somazina and Ceraxon. In the US, it is available primarily as a dietary supplement under the brand Cognizin. Strengths range from 250 mg to 1000 mg for oral use and 100 mg/mL for injections. Citicoline boosts phospholipid synthesis and brain energy metabolism. Pharmacies, hospitals, and B2B pharmaceutical buyers rely on high-quality Citicoline formulations for neurological health support and clinical neurotherapy programs.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications